Corporate Advisor to Epitan
advice of capital raising options and placements of shares
In 2005 we assisted an ASX listed bio-tech, Epitan Limited (now
called Clinuval Pharmaceuticals), in two institutional equity raisings
totalling $10.4m and a related Share Purchase Plan for shareholders.
The institutional raising included institutions based in both Europe